Megan S. Kane

FYI MedlinePlus has a ton of developer tools that may be easier than trying to get their data via MedGen (which we process but haven't put out in FTP reports...

In following up with this issue and the ping about it again during the Mondo call, I was able to pull a one-off report together for you all based on...

@matentzn I will discuss with our devs and see what we can do. It would probably be a few months before we'd release an updated report (if we incorporate it...

@matentzn We are not able to generate a report/table like this at this time from the MedGen side. I'll make a note of this request for the improvements we're planning,...

@twhetzel - FYI if the condition name in that table has no hyperlink, it's not assigned a CUI in MedGen so it's highly unlikely it's in Mondo already (our logic...

@MeeSiing did this merge not make it into the Dec 25 release? It looks like both Mondo IDs are still active. We are working on updating MedGen with the latest...

@MickeySegal MedGen has drug sensitivity/abnormal response terms: https://www.ncbi.nlm.nih.gov/medgen/324697 (Codeine) https://www.ncbi.nlm.nih.gov/medgen/?term=Warfarin+sensitivity%2C+X-linked and https://www.ncbi.nlm.nih.gov/medgen/148193 (two Warfarin terms) https://www.ncbi.nlm.nih.gov/medgen/?term=Mercaptopurine+response We'd love it if another group took up the charge to standardize the concepts...

This issue needs a revisit, as OMIM recently updated their entry for this and have multiple families that support a TGFB2-caused form of Camurati-Engelmann disease (aka type 2), plus an...

I agree that progeria vs. progeroid syndrome needs a clearer definition, but I do not think it is ontologically correct to merge these two. The "progeria" record reflect the OMIM...

@sabrinatoro this is not a problem we'll update the OMIM mappings. but the MedGen concept will remain active for HPO. thanks for the heads up